Advertisement
Screener

Fortress Biotech, Inc. (FBIO) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number

Fortress Biotech, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number

Fortress Biotech, Inc. (FBIO) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number of 18.90 thousand shares as of 2025-09-30, per its 10-Q filed 2025-11-14.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber · last filed 2026-03-31

  • 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 18.90K shares.
  • 2025-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 18.90K shares.
  • 2025-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 18.90K shares.
  • 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 558.90K shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, NumberShare-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number as first filed
2025-09-3018.90K shares
10-Q · filed 2025-11-14
2025-06-3018.90K shares
10-Q · filed 2025-08-14
2025-03-3118.90K shares
10-Q · filed 2025-05-15
2024-12-31558.90K shares
10-K · filed 2026-03-31
2024-09-30558.90K shares
10-Q · filed 2024-11-14
2024-06-30558.90K shares
10-Q · filed 2024-08-13
2024-03-31558.90K shares
10-Q · filed 2024-05-15
2023-12-3118.90K shares
10-K · filed 2025-03-31
2023-09-30160.23K shares
10-Q · filed 2023-11-14
2023-06-302.40M shares
10-Q · filed 2023-08-14
2023-03-312.60M shares
10-Q · filed 2023-05-15
2022-12-31176.73K shares
10-K · filed 2024-03-28
2.65M shares
10-K · filed 2023-03-31
2022-09-30650.99K shares
10-Q · filed 2022-11-14
2022-06-30705.99K shares
10-Q · filed 2022-08-11
2022-03-31765.99K shares
10-Q · filed 2022-05-12
2021-12-311.02M shares
10-K · filed 2023-03-31
2021-09-301.02M shares
10-Q · filed 2021-11-15
2021-06-301.03M shares
10-Q · filed 2021-08-16
2021-03-311.03M shares
10-Q · filed 2021-05-17
2020-12-311.05M shares
10-K · filed 2023-03-31
2020-09-301.06M shares
10-Q · filed 2020-11-09
2020-06-301.41M shares
10-Q · filed 2020-08-10
2020-03-311.41M shares
10-Q · filed 2020-05-11
2019-12-311.41M shares
10-K · filed 2022-03-28
2019-09-301.41M shares
10-Q · filed 2019-11-12
2019-06-301.41M shares
10-Q · filed 2019-08-09
2019-03-311.09M shares
10-Q · filed 2019-05-10
2018-12-311.29M shares
10-K/A · filed 2021-04-09
1.09M shares
10-K · filed 2019-03-18
2017-12-311.31M shares
10-K · filed 2020-03-16
1.09M shares
10-K · filed 2018-03-16
2017-09-301.10M shares
10-Q · filed 2017-11-09
2017-06-301.11M shares
10-Q · filed 2017-08-09
2017-03-311.13M shares
10-Q · filed 2017-05-10
2016-12-311.11M shares
10-K · filed 2019-03-18
1.13M shares
10-K · filed 2017-03-16
2015-12-311.78M shares
10-K · filed 2018-03-16
2014-12-312.16M shares
10-K · filed 2015-03-16
2014-09-302.16B shares
10-Q · filed 2014-11-06
2014-06-302.16B shares
10-Q · filed 2014-08-11
2014-03-312.26B shares
10-Q · filed 2014-05-12
2013-12-313.12M shares
10-K · filed 2014-03-14
2013-09-304.13M shares
10-Q · filed 2013-11-01
2013-06-304.29M shares
10-Q · filed 2013-08-05
2013-03-314.10M shares
10-Q · filed 2013-05-09
2012-12-312.52M shares
10-K · filed 2013-03-18
2012-09-302.41M shares
10-Q · filed 2012-11-14
2012-06-302.35M shares
10-Q · filed 2012-08-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
ALX ONCOLOGY HOLDINGS INC (ALXO)United States$0.187B-3.52
PepGen Inc. (PEPG)United States$0.186B-1.73
AN2 Therapeutics, Inc. (ANTX)United States$0.185B-4.84
Organogenesis Holdings Inc. (ORGO)United States$0.182B-3.70
Zentalis Pharmaceuticals, Inc. (ZNTL)United States$0.196B-2.48
ORAMED PHARMACEUTICALS INC. (ORMP)$0.199B1.13
Nkarta, Inc. (NKTX)United States$0.205B-1.73
Tonix Pharmaceuticals Holding Corp. (TNXP)United States$0.166B-1.34
Minerva Neurosciences, Inc. (NERV)United States$0.165B-0.66
ADC Therapeutics SA (ADCT)$0.163B-1.39